CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (905) 475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- 4 Grant or award Chief Executive Officer acquired 4,015 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 4,785 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 3,083 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 3,253 shares (grant or award)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $4.00 ($20,000)
- 4 Grant or award Chief Executive Officer acquired 2,765 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 2,978 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 2,908 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 17,400 shares (grant or award)
- 4 Grant or award President acquired 93,200 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 99,300 shares (grant or award)
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
Page 4 of 14 · 261 filings